We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$1.83B
AUM Growth
-$162M
Cap. Flow
-$224M
Cap. Flow %
-12.21%
Top 10 Hldgs %
10.93%
Holding
2,251
New
495
Increased
616
Reduced
729
Closed
395

Sector Composition

Rank Sector Weight
1 Technology 17.35%
2 Financials 12.93%
3 Industrials 11.95%
4 Consumer Discretionary 11.81%
5 Healthcare 11.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SN
1801
DELISTED
Sanchez Energy Corporation
SN
$16K ﹤0.01%
7,084
-4,604
-39% -$15.9K
BEAT
1802
DELISTED
BioTelemetry, Inc.
BEAT
$16K ﹤0.01%
254
-400
-61% -$22.3K
ATRC icon
1803
AtriCure
ATRC
$2.06B
$15K ﹤0.01%
+421
New +$13.3K
ROKU icon
1804
Roku
ROKU
$22.7B
$15K ﹤0.01%
200
-1,265
-86% -$72.5K
SRRA
1805
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$15K ﹤0.01%
225
+12
+6% +$1.09K
QTRH
1806
DELISTED
Quarterhill Inc. Common Shares
QTRH
$15K ﹤0.01%
+10,380
New +$13.4K
AKBA icon
1807
Akebia Therapeutics
AKBA
$249M
$14K ﹤0.01%
1,529
-12,204
-89% -$109K
TNK icon
1808
Teekay Tankers
TNK
$2.65B
$14K ﹤0.01%
+1,754
New +$14.6K
GEN
1809
DELISTED
Genesis Healthcare, Inc.
GEN
$14K ﹤0.01%
10,102
+3,002
+42% +$4.75K
FET icon
1810
Forum Energy Technologies
FET
$859M
$13K ﹤0.01%
61
+54
+771% +$12.7K
MIDD icon
1811
Middleby
MIDD
$6.06B
$13K ﹤0.01%
101
-1,276
-93% -$146K
ITCI
1812
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$13K ﹤0.01%
600
-9,041
-94% -$189K
ESTA icon
1813
Establishment Labs
ESTA
$2.32B
$12K ﹤0.01%
+508
New +$13K
SPRO icon
1814
Spero Therapeutics
SPRO
$72.4M
$11K ﹤0.01%
+1,006
New +$11.7K
TVTX icon
1815
Travere Therapeutics
TVTX
$5.87B
$11K ﹤0.01%
371
-24,829
-99% -$710K
ENLC
1816
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
$11K ﹤0.01%
+691
New +$11.5K
SPPI
1817
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$11K ﹤0.01%
+635
New +$13.7K
CHMA
1818
DELISTED
Chiasma, Inc. Common Stock
CHMA
$11K ﹤0.01%
+3,100
New +$6.49K
FNSR
1819
DELISTED
Finisar Corp
FNSR
$11K ﹤0.01%
+599
New +$11.1K
AMP icon
1820
Ameriprise Financial
AMP
$48.8B
$10K ﹤0.01%
69
-11,375
-99% -$1.63M
EYE icon
1821
National Vision
EYE
$1.81B
$10K ﹤0.01%
+229
New +$9.66K
SFUN
1822
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$10K ﹤0.01%
77
-1,338
-95% -$203K
FLY
1823
DELISTED
Fly Leasing Limited
FLY
$10K ﹤0.01%
696
-3,521
-83% -$49.8K
BLUE
1824
DELISTED
bluebird bio
BLUE
$9K ﹤0.01%
5
-1,848
-100% -$3.82M
CSIQ icon
1825
Canadian Solar
CSIQ
$1.07B
$9K ﹤0.01%
+608
New +$8.38K

Similar funds

Cubist Systematic Strategies's Q3 2018 Portfolio in Review

As of Q3 2018, Cubist Systematic Strategies held 2,251 positions worth $1.83B, down 8.1% from $1.99B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Cubist Systematic Strategies withdrew a net $224M in Q3 2018, closing 395 positions and reducing 729 holdings. Its most notable exit was RealPage, Inc., an estimated $7.21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

Against the trend, Cubist Systematic Strategies opened a new position in NXP Semiconductors worth $17.6M.

  • Cubist Systematic Strategies's largest Q3 2018 buy was NXP Semiconductors: 205,779 shares worth $17.6M.
  • Cubist Systematic Strategies added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $65.8M increase.
  • Cubist Systematic Strategies's biggest Q3 2018 reduction was Just Eat Takeaway.com N.V. American Depositary Shares, cutting an estimated $13.2M.
  • Cubist Systematic Strategies fully exited RealPage, Inc. in Q3 2018, selling an estimated $7.21M.
  • Cubist Systematic Strategies's ten largest holdings make up 11% of its $1.83B portfolio in Q3 2018.
  • Cubist Systematic Strategies opened 495 new positions and closed 395 in Q3 2018.
  • Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $1.83B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.